Nitazoxanide
Medicare prescription drug cost, prescriptions and prescribers, 2024
$4.0M
Medicare cost, 2024
$4.0M
Medicare cost, 2024
Medicare drug plans spent $4.0 million on Nitazoxanide in 2024, for 3,287 prescriptions and refills filled by 2,649 patients. It was first approved in 2020. California accounts for the most spending ($463,728, 11% of the total).
Medicare cost, 2024
$4.0M
-15.0% from 2023
Prescriptions
3,287
$1,229.10 per claim
Patients
2,649
2,394 prescribers
Total spending, 2024
$4.1M
$1,531.38 per patient
Questions and answers
How much does Medicare spend on Nitazoxanide?
Medicare prescription drug plans paid $4.0M for Nitazoxanide in 2024, for 3,287 prescriptions and refills to 2,649 patients (down 15.0% from 2023). The average cost per claim was $1,229.10.
Which state spends the most on Nitazoxanide?
California had the highest Medicare cost for Nitazoxanide in 2024: $464K for 297 claims, followed by Texas ($403K).
Who prescribes Nitazoxanide the most?
Patrick Dorvilus, internal medicine in Statesboro, GA, had the highest Medicare cost for Nitazoxanide in 2024: 15 claims costing $42K.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Nitazoxanide was $4.1M in 2024, after a high of $5.4M in 2022.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Nitazoxanide, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Patrick Dorvilus Statesboro, GA | Internal Medicine | 15 | 13 | $42K |
| Patrick J Mulcahy Kennebunk, ME | Family Practice | 12 | Under 11 | $36K |
| Michael T Jelinek Edinburg, TX | Infectious Disease | 15 | Under 11 | $32K |
| Joseph M Hathaway Jr. Statesboro, GA | Gastroenterology | 11 | Under 11 | $29K |
| Bassem Mazloum San Antonio, TX | Gastroenterology | 16 | Under 11 | $27K |
| Amir T Awad Tampa, FL | Gastroenterology | 31 | 21 | $26K |
| Jeremy D Frix Meridian, ID | Physician Assistant | 12 | Under 11 | $24K |
| Samuel A Banigo Irvington, NJ | Internal Medicine | 14 | Under 11 | $21K |
| Isaac Melamed Centennial, CO | Allergy/ Immunology | 28 | 14 | $18K |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,309 | 3,366 | 2,618 | $5.4M |
| 2023 | 2,345 | 3,354 | 2,609 | $4.8M |
| 2024 | 2,394 | 3,287 | 2,649 | $4.0M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Rising Pharm | 3,234 | $4.0M |
| Lupin Pharmaceu | 72 | $62K |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 9
- RxNorm concept IDs
- 427163
- Application numbers
- ANDA213820, ANDA214844, ANDA218701
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 349 side-effect reports named nitazoxanide (reports from 2005 on). 319 of them (91.4%) were serious, 75 named a death and 141 named a hospital stay. The reactions named most often were diarrhoea, drug ineffective and off label use. 191 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
349
48 in 2025 (-18.6% from 2024)
Serious
91.4%
319 reports
Deaths named
75
21.5% of reports
Hospital stays
141
40.4% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Nitazoxanide?
349 reports from 2005 through September 2026 named nitazoxanide. 319 of them (91.4%) were serious, 75 named a death and 141 named a hospital stay.
What are the most reported side effects of Nitazoxanide?
68 reports named diarrhoea, the reaction named most often, followed by drug ineffective (57) and off label use (54). In the last 5 years the reaction named most often was diarrhoea (45 reports). A report can name several reactions.
How many side-effect reports named Nitazoxanide in 2025?
48 reports were received in 2025 (-18.6% from 2024). 2026 so far: 29 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Nitazoxanide caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Nitazoxanide caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Drug approvals (3 approvals on file for nitazoxanide) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (nitazoxanide) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.